TMP Associates II LP
Insider CIK 1383035 · OCRX 10% owner · CRXT 10% owner · ASPX Director, 10% owner · NVTA 10% owner · CRXT 10% owner · CASM 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRXT CLARUS THERAPEUTICS INC | S Sale | 2022-04-20 | 2022-04-21 | 1,663,126 | $2.53 | $4.21M | 773,599 | SEC↗ |
| CRXT CLARUS THERAPEUTICS INC | S Sale | 2022-04-20 | 2022-04-21 | 13,630 | $2.53 | $34.5K | 6,340 | SEC↗ |
| CRXT CLARUS THERAPEUTICS INC | S Sale | 2022-04-20 | 2022-04-21 | 1,164 | $2.53 | $2.9K | 542 | SEC↗ |
| CRXT CLARUS THERAPEUTICS INC | S Sale | 2022-04-20 | 2022-04-21 | 7,585 | $2.53 | $19.2K | 3,528 | SEC↗ |
| CRXT CLARUS THERAPEUTICS INC | S Sale | 2022-04-20 | 2022-04-21 | 5,722 | $2.53 | $14.5K | 2,661 | SEC↗ |
| CRXT CLARUS THERAPEUTICS INC | S Sale | 2022-04-20 | 2022-04-21 | 2,061,685 | $2.53 | $5.22M | 958,989 | SEC↗ |
| CRXT Clarus Therapeutics Holdin | S Sale | 2022-04-20 | 2022-04-25 | 13,630 | $2.53 | $34.5K | 6,340 | SEC↗ |
| CRXT Clarus Therapeutics Holdin | S Sale | 2022-04-20 | 2022-04-25 | 2,061,685 | $2.53 | $5.22M | 958,989 | SEC↗ |
| CRXT Clarus Therapeutics Holdin | S Sale | 2022-04-20 | 2022-04-25 | 1,164 | $2.53 | $2.9K | 542 | SEC↗ |
| CRXT Clarus Therapeutics Holdin | S Sale | 2022-04-20 | 2022-04-25 | 5,722 | $2.53 | $14.5K | 2,661 | SEC↗ |
| CRXT Clarus Therapeutics Holdin | S Sale | 2022-04-20 | 2022-04-25 | 1,663,126 | $2.53 | $4.21M | 773,599 | SEC↗ |
| CRXT Clarus Therapeutics Holdin | S Sale | 2022-04-20 | 2022-04-25 | 7,585 | $2.53 | $19.2K | 3,528 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | C Conversion deriv | 2019-04-18 | 2019-04-22 | 94,182 | — | $0 | 0 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | C Conversion deriv | 2019-04-18 | 2019-04-22 | 561 | — | $0 | 0 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | C Conversion deriv | 2019-04-18 | 2019-04-22 | 191 | — | $0 | 0 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | C Conversion deriv | 2019-04-18 | 2019-04-22 | 53,748 | — | $0 | 0 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | C Conversion deriv | 2019-04-18 | 2019-04-22 | 984 | — | $0 | 0 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | C Conversion deriv | 2019-04-18 | 2019-04-22 | 334 | — | $0 | 0 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | D To issuer | 2019-04-18 | 2019-04-22 | 43,944 | $2.45 | $107.7K | 0 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | D To issuer | 2019-04-18 | 2019-04-22 | 12,300,186 | $2.45 | $30.14M | 0 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | C Conversion | 2019-04-18 | 2019-04-22 | 40,772 | $2.39 | $97.4K | 119,872 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | C Conversion | 2019-04-18 | 2019-04-22 | 13,881 | $2.39 | $33.2K | 43,944 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | C Conversion | 2019-04-18 | 2019-04-22 | 3,906,315 | $2.39 | $9.34M | 12,300,186 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | D To issuer | 2019-04-18 | 2019-04-22 | 119,872 | $2.45 | $293.7K | 0 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | C Conversion | 2019-04-18 | 2019-04-22 | 24,125 | $2.39 | $57.7K | 30,063 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | C Conversion | 2019-04-18 | 2019-04-22 | 6,802,834 | $2.39 | $16.26M | 8,393,871 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | C Conversion | 2019-04-18 | 2019-04-22 | 71,075 | $2.39 | $169.9K | 79,100 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | U Tender | 2015-05-05 | 2015-05-07 | 4,835,731 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | C Conversion deriv | 2015-02-18 | 2015-02-18 | 2,500,000 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | C Conversion deriv | 2015-02-18 | 2015-02-18 | 3,267,973 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | C Conversion deriv | 2015-02-18 | 2015-02-18 | 5,263,155 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | C Conversion deriv | 2015-02-18 | 2015-02-18 | 11,363,636 | — | $0 | 0 | SEC↗ |
| NVTA Invitae Corp | C Conversion | 2015-02-18 | 2015-02-18 | 3,732,460 | — | $0 | 3,732,460 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | P Buy | 2015-02-11 | 2015-02-13 | 1,591,037 | $1.30 | $2.07M | 1,632,945 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | P Buy | 2015-02-11 | 2015-02-13 | 8,025 | $1.30 | $10.4K | 8,025 | SEC↗ |
| CASM CAS MEDICAL SYSTEMS INC | P Buy | 2015-02-11 | 2015-02-13 | 5,938 | $1.30 | $7.7K | 5,938 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2015-01-28 | 2015-01-30 | 730,000 | $53.11 | $38.77M | 4,835,731 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise deriv | 2015-01-08 | 2015-01-12 | 59,277 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise deriv | 2015-01-08 | 2015-01-12 | 169,630 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise deriv | 2015-01-08 | 2015-01-12 | 90,228 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise | 2015-01-08 | 2015-01-12 | 319,135 | $3.88 | $1.24M | 5,589,739 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | D To issuer | 2015-01-08 | 2015-01-12 | 24,008 | $51.57 | $1.24M | 5,565,731 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise deriv | 2014-10-09 | 2014-10-14 | 60,151 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | D To issuer | 2014-10-09 | 2014-10-14 | 9,771 | $23.89 | $233.4K | 5,270,604 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise | 2014-10-09 | 2014-10-14 | 60,151 | $3.88 | $233.4K | 5,280,375 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise deriv | 2014-05-14 | 2014-09-09 | 65,839 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise deriv | 2014-05-14 | 2014-09-09 | 65,839 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise deriv | 2014-05-14 | 2014-09-19 | 65,839 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-05-14 | 2014-09-09 | 12,400 | $20.60 | $255.4K | 5,220,224 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise | 2014-05-14 | 2014-09-09 | 65,839 | $3.88 | $255.5K | 5,232,624 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | X Exercise | 2014-05-14 | 2014-09-09 | 65,839 | $3.88 | $255.5K | 5,232,624 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | S Sale | 2014-05-14 | 2014-09-09 | 12,400 | $20.60 | $255.4K | 5,220,224 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | D To issuer | 2014-05-14 | 2014-09-19 | 12,400 | $20598.00 | $255.42M | 5,220,224 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | M Exercise | 2014-05-14 | 2014-09-19 | 65,839 | $3.88 | $255.5K | 5,232,624 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 270,687 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 406,032 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 169,630 | — | $0 | 169,630 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 763,340 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 59,277 | — | $0 | 59,277 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 266,750 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 60,151 | — | $0 | 60,151 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 90,228 | — | $0 | 90,228 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 65,839 | — | $0 | 65,839 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 296,281 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 1,118,298 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 11,915,254 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 7,552,207 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion deriv | 2014-02-10 | 2014-02-12 | 2,289,771 | — | $0 | 0 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | P Buy | 2014-02-10 | 2014-02-12 | 83,334 | $12.00 | $1.00M | 5,166,785 | SEC↗ |
| ASPX Auspex Pharmaceuticals, In | C Conversion | 2014-02-10 | 2014-02-12 | 5,083,451 | — | $0 | 5,083,451 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2013-07-15 | 2013-07-17 | 1,751,393 | $6.00 | $10.51M | 1,751,393 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2013-07-15 | 2013-07-17 | 687,176 | $6.00 | $4.12M | 687,176 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2012-10-01 | 2013-07-17 | 161,855 | $44.23 | $7.16M | 161,855 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2012-08-07 | 2013-07-17 | 31,835 | — | $0 | 31,835 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2012-03-30 | 2013-07-17 | 161,855 | $44.23 | $7.16M | 161,855 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2011-04-19 | 2013-07-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2010-02-11 | 2013-07-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2009-02-11 | 2013-07-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2006-02-06 | 2013-07-17 | 100,000 | — | $0 | 100,000 | SEC↗ |